Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 11, 2010

Sigma-Aldrich Licenses RAFT Polymerization Technology from CSIRO

  • Sigma-Aldrich entered into a worldwide licensing agreement with Australia's Commonwealth Scientific and Industrial Research Organization (CSIRO) to manufacture and sell reversible addition-fragmentation chain transfer (RAFT) agents, organic molecules that can be added to polymerization reactions to precisely control molecular weights and structures of polymers. Under the terms of the agreement, Sigma-Aldrich has the rights to manufacture and sell the RAFT agents worldwide for all R&D applications.

    Polymers designed using RAFT technology can be used to prepare materials with unique properties controlled by their nanometer-scale molecular architecture in industries such as biomedical, specialty chemical, and personal care, Sigma-Aldrich explains. The RAFT method is applicable to a wide range of monomers and experimental conditions. Sigma-Aldrich currently offers seven RAFT agents that can be supplied in quantities from standard 1 g and 5 g packs to several hundred grams and expects to make additional RAFT agents available later in 2010.



Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »